BioBridgeXAll companies

Syntis Bio, Inc.

Biotechnology company · Boston, Massachusetts, United States

Syntis Bio, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2022. It has received 7 US government small-business research awards (SBIR/STTR) from health agencies, $3.8 million in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2025.

www.syntis.bioProfile compiled from public records. Is this your company? Request a correction or update

Syntis Bio at a glance

Typebiotechnology company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2022
Employees (per SBIR records)12
SEC CIK1943061

What does Syntis Bio do?

US government research funding

7 SBIR/STTR small-business research awards from US health agencies, $3.8 million in total (2024 to 2025). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Child Health and Human Development.

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $25 million sold (2025).

Frequently asked questions about Syntis Bio

Where is Syntis Bio headquartered?

Syntis Bio, Inc. is headquartered in Boston, Massachusetts, United States.

What does Syntis Bio do?

Syntis Bio, Inc. is a biotechnology company.

When was Syntis Bio founded?

The earliest incorporation on record for Syntis Bio, Inc. is in 2022, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.